Curetopia raises $1.77 million to accelerate rare disease treatment through the use of cryptocurrency

According to BlockBeats, on March 25th, Curetopia, a Solana based BioDAO project, has successfully raised $1.77 million through Bio Protocol Launchpad (a decentralized science platform supported by Binance, abbreviated as DeSci) to develop treatment options for the rare disease market. The size and opportunities of the rare disease market exceed $1 trillion. In the past few months, DeSci has successfully secured over $15 million in research funding to support scientists in addressing the challenges posed by funding freezes at the National Institutes of Health (NIH) and the National Science Foundation (NSF) in the United States. Curetopia is accelerating the development of drugs for over 10000 rare diseases that are often overlooked by large pharmaceutical companies, with an average market size of $200 million to $300 million for each disease. This financing is made after Curetopia's breakthrough discovery, which may become a potential treatment for AARS2 (a disease for which there is currently no approved treatment plan). Curetopia plans to apply for a temporary patent based on this discovery and tokenize it, with the proceeds flowing back into the value of DAO tokens. The mode of Curetopia is not limited to AARS2. The decentralized, AI driven approach of this DAO can be applied to thousands of rare diseases, with an average market size of $200 million to $300 million for each disease. In the initial stage, Curetopia will develop treatment plans by reusing approved drugs to bypass regulatory bottlenecks and accelerate treatment delivery. Curetopia, led by Harvard PhD and Y Combinator alumnus Ethan Perlstein, aims to drive innovative treatments for over 10000 rare diseases through decentralized science (DeSci).